mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.004 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |